These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 21131051

  • 1. Protection against malaria is conferred by passive transferring rabbit F(ab)(2)' antibody fragments, induced by Plasmodium falciparum MSP-1 site-directed designed pseudopeptide-BSA conjugates assessed in a rodent model.
    Lozano JM, Lesmes LP, Gallego GM, Patarroyo ME.
    Mol Immunol; 2011 Jan; 48(4):657-69. PubMed ID: 21131051
    [Abstract] [Full Text] [Related]

  • 2. Passive transfer of Plasmodium falciparum MSP-2 pseudopeptide-induced antibodies efficiently controlled parasitemia in Plasmodium berghei-infected mice.
    Martínez PA, Yandar N, Lesmes LP, Forero M, Pérez-Leal O, Patarroyo ME, Lozano JM.
    Peptides; 2009 Feb; 30(2):330-42. PubMed ID: 19071172
    [Abstract] [Full Text] [Related]

  • 3. Antibodies induced by Plasmodium falciparum merozoite surface antigen-2-designed pseudopeptides possess neutralizing properties of the in vitro malarial infection.
    Lozano JM, Montoya-Fajardo FJ, Hoebeke J, Cifuentes GH, Forero M, Patarroyo ME.
    Peptides; 2007 Oct; 28(10):1954-65. PubMed ID: 17881088
    [Abstract] [Full Text] [Related]

  • 4. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
    Rotman HL, Daly TM, Long CA.
    Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
    [Abstract] [Full Text] [Related]

  • 5. Mapping the anatomy of a Plasmodium falciparum MSP-1 epitope using pseudopeptide-induced mono- and polyclonal antibodies and CD and NMR conformation analysis.
    Lozano JM, Espejo F, Ocampo M, Salazar LM, Tovar D, Barrera N, Guzmán F, Patarroyo ME.
    J Struct Biol; 2004 Oct; 148(1):110-22. PubMed ID: 15363791
    [Abstract] [Full Text] [Related]

  • 6. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria.
    Daly TM, Long CA.
    J Immunol; 1995 Jul 01; 155(1):236-43. PubMed ID: 7602100
    [Abstract] [Full Text] [Related]

  • 7. MSP-1 malaria pseudopeptide analogs: biological and immunological significance and three-dimensional structure.
    Lozano JM, Alba MP, Vanegas M, Silva Y, Torres-Castellanos JL, Patarroyo ME.
    Biol Chem; 2003 Jan 01; 384(1):71-82. PubMed ID: 12674501
    [Abstract] [Full Text] [Related]

  • 8. Plasmodium yoelii: the role of the individual epidermal growth factor-like domains of the merozoite surface protein-1 in protection from malaria.
    Calvo PA, Daly TM, Long CA.
    Exp Parasitol; 1996 Jan 01; 82(1):54-64. PubMed ID: 8617331
    [Abstract] [Full Text] [Related]

  • 9. Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1.
    Hirunpetcharat C, Vukovic P, Liu XQ, Kaslow DC, Miller LH, Good MF.
    J Immunol; 1999 Jun 15; 162(12):7309-14. PubMed ID: 10358180
    [Abstract] [Full Text] [Related]

  • 10. Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge.
    Wang L, Goschnick MW, Coppel RL.
    Infect Immun; 2004 Oct 15; 72(10):6172-5. PubMed ID: 15385527
    [Abstract] [Full Text] [Related]

  • 11. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.
    Rotman HL, Daly TM, Clynes R, Long CA.
    J Immunol; 1998 Aug 15; 161(4):1908-12. PubMed ID: 9712060
    [Abstract] [Full Text] [Related]

  • 12. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
    Wang R, Charoenvit Y, Corradin G, Porrozzi R, Hunter RL, Glenn G, Alving CR, Church P, Hoffman SL.
    J Immunol; 1995 Mar 15; 154(6):2784-93. PubMed ID: 7876549
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.
    Jeamwattanalert P, Mahakunkijcharoen Y, Kittigul L, Mahannop P, Pichyangkul S, Hirunpetcharat C.
    Clin Vaccine Immunol; 2007 Apr 15; 14(4):342-7. PubMed ID: 17314232
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Protection against malaria induced by chirally modified Plasmodium falciparum's MSP-1 42 pseudopeptides.
    Lozano JM, Espejo F, Vera R, Vargas LE, Rosas J, Lesmes L, Torres E, Cortés J, Silva Y, Patarroyo ME.
    Biochem Biophys Res Commun; 2005 Apr 15; 329(3):1053-66. PubMed ID: 15752762
    [Abstract] [Full Text] [Related]

  • 17. Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparum.
    Cheng XJ, Hayasaka H, Watanabe K, Tao YL, Liu JY, Tsukamoto H, Horii T, Tanabe K, Tachibana H.
    Infect Immun; 2007 Jul 15; 75(7):3614-20. PubMed ID: 17452466
    [Abstract] [Full Text] [Related]

  • 18. Active and passive immunization against Plasmodium yoelii sporozoites.
    Charoenvit Y, Sedegah M, Yuan LF, Gross M, Cole C, Bechara R, Leef MF, Robey FA, Lowell GH, Beaudoin RL.
    Bull World Health Organ; 1990 Jul 15; 68 Suppl(Suppl):26-32. PubMed ID: 1709834
    [Abstract] [Full Text] [Related]

  • 19. Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum.
    Woehlbier U, Epp C, Kauth CW, Lutz R, Long CA, Coulibaly B, Kouyaté B, Arevalo-Herrera M, Herrera S, Bujard H.
    Infect Immun; 2006 Feb 15; 74(2):1313-22. PubMed ID: 16428781
    [Abstract] [Full Text] [Related]

  • 20. The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii merozoite surface protein 1-19 (MSP1(19)).
    Adame-Gallegos JR, Shi J, McIntosh RS, Pleass RJ.
    Exp Parasitol; 2012 Apr 15; 130(4):384-93. PubMed ID: 22343045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.